FNDC5 and gastric cancer: Finally, measurements of the serum irisin levels in healthy and newly diagnosed gastric cancer (GC) patients found significantly higher levels in gastric cancer patients compared to healthy controls, suggesting a possible role of serum irisin as a biomarker of GC disease diagnoses [100].